1. Tremella fuciformis polysaccharides ameliorated ulcerative colitis via inhibiting inflammation and enhancing intestinal epithelial barrier function
- Author
-
Qingping Xiong, Jian Liang, Shaozhen Hou, Hailun Li, Song Huang, Shumin Zhu, Jie Gao, Dong-xu Jiang, Lian He, Xueling He, Hongyu Xiao, and Yifan Wen
- Subjects
Male ,Lipopolysaccharide ,Cell Survival ,Colon ,Inflammation ,02 engineering and technology ,Pharmacology ,Biochemistry ,03 medical and health sciences ,chemistry.chemical_compound ,Microscopy, Electron, Transmission ,Polysaccharides ,Structural Biology ,medicine ,Animals ,Humans ,Intestinal Mucosa ,Molecular Biology ,Barrier function ,030304 developmental biology ,Mice, Inbred BALB C ,0303 health sciences ,Intestinal permeability ,biology ,Reverse Transcriptase Polymerase Chain Reaction ,Chemistry ,Basidiomycota ,Tremella fuciformis ,Dextran Sulfate ,General Medicine ,021001 nanoscience & nanotechnology ,medicine.disease ,biology.organism_classification ,Mucus ,Ulcerative colitis ,In vitro ,Disease Models, Animal ,Gene Expression Regulation ,Colitis, Ulcerative ,Caco-2 Cells ,medicine.symptom ,0210 nano-technology - Abstract
The purpose of this paper was to explore the therapeutic effect and underlying mechanism of Tremella fuciformis polysaccharides (TFP) on ulcerative colitis (UC) based on dextran sodium sulfate (DSS)-induced mice UC model and lipopolysaccharide (LPS)-stimulated Caco-2 cells model. The results firstly indicated that TFP can significantly alleviate the symptoms and signs of the DSS-induced mice UC model, which manifests as improvement of body weight loss, increase of colon length, decrease of colon thickness and reduction of intestinal permeability. Then, results from histopathological and electron microscope analysis further implied that TFP could dramatically reduce inflammatory cells infiltration and restore intestinal epithelial barrier integrity. In addition, the experiments of LPS-stimulated Caco-2 cells model in vitro also further confirmed that TFP could markedly inhibit the expressions of pro-inflammatory cytokines and increase related genes or proteins expressions of intestinal barrier and mucus barrier. Taken together, these data suggested that TFP has a significant therapeutic effect on DSS-induced UC model, and its mechanisms are closely linked to the inhibition of inflammation and the restoration of intestinal barrier and mucus barrier function. These beneficial effects may make TFP a promising drug to be used in alleviating UC.
- Published
- 2021
- Full Text
- View/download PDF